GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (CHIX:GUBRAc) » Definitions » Piotroski F-Score

Gubra AS (CHIX:GUBRAC) Piotroski F-Score : 5 (As of Dec. 11, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Gubra AS has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Gubra AS's Piotroski F-Score or its related term are showing as below:

CHIX:GUBRAc' s Piotroski F-Score Range Over the Past 10 Years
Min: 5   Med: 5   Max: 9
Current: 5

During the past 5 years, the highest Piotroski F-Score of Gubra AS was 9. The lowest was 5. And the median was 5.


Gubra AS Piotroski F-Score Historical Data

The historical data trend for Gubra AS's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Piotroski F-Score Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
N/A N/A 9.00 5.00 5.00

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Piotroski F-Score Get a 7-Day Free Trial - 5.00 - 5.00 -

Competitive Comparison of Gubra AS's Piotroski F-Score

For the Biotechnology subindustry, Gubra AS's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gubra AS's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Gubra AS's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was kr-44.5 Mil.
Cash Flow from Operations was kr-49.4 Mil.
Revenue was kr205.0 Mil.
Gross Profit was kr114.9 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was (262.902 + 625.28) / 2 = kr444.091 Mil.
Total Assets at the begining of this year (Dec22) was kr262.9 Mil.
Long-Term Debt & Capital Lease Obligation was kr60.7 Mil.
Total Current Assets was kr542.0 Mil.
Total Current Liabilities was kr84.1 Mil.
Net Income was kr4.3 Mil.

Revenue was kr199.4 Mil.
Gross Profit was kr97.7 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was (302.125 + 262.902) / 2 = kr282.5135 Mil.
Total Assets at the begining of last year (Dec21) was kr302.1 Mil.
Long-Term Debt & Capital Lease Obligation was kr61.0 Mil.
Total Current Assets was kr192.0 Mil.
Total Current Liabilities was kr93.7 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Gubra AS's current Net Income (TTM) was -44.5. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Gubra AS's current Cash Flow from Operations (TTM) was -49.4. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-44.524/262.902
=-0.16935588

ROA (Last Year)=Net Income/Total Assets (Dec21)
=4.31/302.125
=0.01426562

Gubra AS's return on assets of this year was -0.16935588. Gubra AS's return on assets of last year was 0.01426562. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Gubra AS's current Net Income (TTM) was -44.5. Gubra AS's current Cash Flow from Operations (TTM) was -49.4. ==> -49.4 <= -44.5 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=60.685/444.091
=0.13664992

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=60.962/282.5135
=0.21578438

Gubra AS's gearing of this year was 0.13664992. Gubra AS's gearing of last year was 0.21578438. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=542.034/84.088
=6.44603273

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=192.014/93.733
=2.0485208

Gubra AS's current ratio of this year was 6.44603273. Gubra AS's current ratio of last year was 2.0485208. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Gubra AS's number of shares in issue this year was 15.171. Gubra AS's number of shares in issue last year was 16.35. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=114.936/205.005
=0.56064974

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=97.745/199.381
=0.4902423

Gubra AS's gross margin of this year was 0.56064974. Gubra AS's gross margin of last year was 0.4902423. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=205.005/262.902
=0.77977726

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=199.381/302.125
=0.65992884

Gubra AS's asset turnover of this year was 0.77977726. Gubra AS's asset turnover of last year was 0.65992884. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+0+1+1+1+1+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Gubra AS has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Gubra AS  (CHIX:GUBRAc) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Gubra AS Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Gubra AS's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS Business Description

Traded in Other Exchanges
Address
Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has three segments: Pre-clinical contract research (CRO), which derives maximum revenue; Discovery & Partnerships (D&P) Segment; and Gubra Green Segment.

Gubra AS Headlines

No Headlines